行情

GCVRZ

GCVRZ

Sanofi FR
NASDAQ

实时行情|Nasdaq Last Sale

0.8590
-0.0010
-0.12%
已收盘, 16:00 11/14 EST
开盘
0.8575
昨收
0.8600
最高
0.8590
最低
0.8573
成交量
7.57万
成交额
--
52周最高
0.8600
52周最低
0.1529
市值
10.75亿
市盈率(TTM)
0.3114
分时
5日
1月
3月
1年
5年

GCVRZ 新闻

  • As swine fever fries China vaccine sales, Boehringer rewrites prescription for recovery
  • Reuters.1天前
  • UPDATE 1-FDA panel votes against Lilly-Boehringer Ingelheim's diabetes drug
  • Reuters.1天前
  • ImmunoGen: Profiting And Turning Around
  • Seeking Alpha - Article.3天前
  • 2 Biotech Stocks Fighting Alzheimer�s Disease to Own Now
  • MotleyFool.com.5天前

更多

所属板块

制药
-0.36%
制药与医学研究
-0.27%

热门股票

名称
价格
涨跌幅

GCVRZ 简况

Sanofi is a healthcare company, focused on patient needs and engaged in the research, development, manufacture and marketing of therapeutic solutions. Its segments are Pharmaceuticals, Human Vaccines (Vaccines), and Other. The Pharmaceuticals segment comprises the commercial operations of various franchises, including Speciality Care (Rare Diseases, Multiple Sclerosis, and Oncology), Diabetes and Cardiovascular, Established Prescription Products, Consumer Healthcare and Generics, and research and development, production and marketing activities for all of the Company's pharmaceuticals operations. The Vaccines segment is dedicated to vaccines and includes the commercial operations of the Company's vaccines division Sanofi Pasteur and dedicated research and development, production and marketing activities for the Company's vaccines operations. Its Rare Diseases products include Cerezyme, Cerdelga, Myozyme and Lumizyme, Fabrazyme, and Aldurazyme. It partners with Alnylam Pharmaceuticals.
展开

Webull提供Sanofi SA的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。